Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction
详细信息 查看全文
- 作者：Kent ; David M. ; Vijan ; Sandeep ; Hayward ; Rodney A. ; Griffith ; John L. ; Beshansky ; Joni R. ; et. al.
- 关键词：Cost benefit analysis ; Myocardial infarction ; Tissue plasminogen ; Activator ; Streptokinase ; Patient selection ; Economic models ; Clinical decision support
- 刊名：Journal of Clinical Epidemiology
- 出版年：2004
- 出版时间：August, 2004
- 年：2004
- 卷：57
- 期：8
- 页码：843-852
- 全文大小：433 K
文摘
We sought to explore the patient-specific cost-effectiveness in a community-based sample for a therapy for which the average cost-effectiveness in a clinical trial has been well-described.